Cancer Prevalence Boosts Biopsy Devices Market Growth

Biopsy Devices Market

As per Inkwood Research, the Global Biopsy Devices Market is expected to develop with a CAGR of 7.23% in terms of revenue during the forecasting years 2024-2032.

“Browse 59 Market Data Tables and 51 Figures spread over 236 Pages, along with an in-depth TOC on the Global Biopsy Devices Market Forecast 2024-2032.” 


Biopsy devices are important in diagnosing and analyzing tumors and other abnormalities, aiding in the effective management of cancer. Their advanced technologies contribute to precise and minimally invasive tissue sampling.


Rising Cancer Incidence Fuels Biopsy Devices Market Growth

Cancer, causing around 10 million deaths globally in 2020, remains a significant contributor to mortality, constituting one-sixth of recorded deaths, as per the World Health Organization (WHO). The prevalent cancer types include breast, lung, colon, rectal, and prostate cancers. The escalating cancer rates highlight the critical role of accurate and early diagnostics, with biopsy devices important. These devices enable healthcare professionals to obtain tissue samples for precise cancer diagnosis and staging. As awareness grows regarding early detection and personalized treatment, there is a notable surge in demand for biopsy devices that support minimally invasive procedures, aiding in the identification and characterization of various cancers.

Oncology to be the Prominent Application Category

Biopsy devices are integral in oncology by obtaining tissue samples for accurate cancer diagnosis, and determining the type, grade, stage, and genetic characteristics. Oncologists use biopsies to assess tumor response to treatments, enabling modifications or alternative therapies. It contributes to customized treatment plans, guiding the selection of chemotherapy, radiation therapy, targeted therapies, or immunotherapy based on the tumor’s molecular profile.

North America: Eminent Region by 2032 

The growing healthcare investment in North America is propelling the biopsy devices market, driven by a focus on advanced diagnostic capabilities. This emphasis on innovative technologies, including biopsy devices, aims to enhance disease detection and improve patient outcomes.

The global biopsy devices market industry rivalry is fiercely competitive, powered by companies striving for distinction through branding and technology. The relentless pursuit of innovation and market leadership shapes the strong sphere of biopsy devices. Some of the leading companies operating in the market are INRAD Inc, DTR Medical, Cardinal Health, Boston Scientific, etc.

Request for Customization

Related Reports:




About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, the Middle East, Europe, Asia, and Africa.

Contact Us